LIBERATI, Anna Marina

LIBERATI, Anna Marina  

Mostra records
Risultati 1 - 20 di 478 (tempo di esecuzione: 0.009 secondi).
Titolo Data di pubblicazione Autore(i) File
5-Fluorouracil, vincristine and hydroxyurea combination chemotherapy in metastatic colorectal cancer. 1983 Liberati, Anna Marina; Di Costanzo, F; Buzzi, F; Fatati, G; Biscottini, B; Ballatori, E; Falchi, R; Grignani, F.
67Ga scan detects residual active disease and it is predictive of disease-free survival in malignant lymphoma patients 1999 Trottini, M.; Palumbo, Isabella; Palumbo, Barbara; Biscottini, B.; Mettivier, V.; Lorusso, V.; Capparella, V.; Moschini, T.; Palumbo, Renato; Liberati, Anna Marina
67Ga scan detects residual active disease and it is predictive of disease-free survival in malignant lymphoma patients. 1999 Palumbo, Isabella; Trottini, M.; Palumbo, Barbara; Biscottini, B.; Mettivier, V.; Lorusso, V.; Moschini, T.; Palumbo, Renato; Liberati, Anna Marina
67Ga-scan detects residual active disease and it is predictive of disease-free survival in classical Hodgkin's disease patients 2004 Trottini, M.; Palumbo, Isabella; Gambacorta, M.; Palumbo, Barbara; Biscottini, B.; Moschini, T.; Capparella, V.; Palumbo, Renato; Liberati, Anna Marina
67Ga-scan usefulness in predicting the clinical outcome and the long-term effects of chemotherapy in lymphoma patients 1999 Palumbo, Isabella; T. O., Moschini; Palumbo, Barbara; Liberati, Anna Marina; M., Trottini; A., Bianchi; Palumbo, Renato
67Ga-SPECT/CT with a hybrid system in the clinical management of lymphoma 2005 Palumbo, Barbara; Sivolella, S; Palumbo, Isabella; Liberati, Anna Marina; Palumbo, Renato
[Metastatic gastric cancer successfully treated with surgery and chemotherapy. Case report]. 2010 Gunnellini, M; Graziosi, L; Emili, R; Bugiantella, W; Ferrazza, P; Cavazzoni, E; Donini, Annibale; Liberati, Anna Marina
A 4-day chemosensitivity assay in vitro reliably predicts clinical response of patients with acute leukemia 1989 Barzi, A; Lepri, Enrica; Menconi, E; Nocentini, Giuseppe; Liberati, Anna Marina; Schippa, M.
A brief course of chemo-immunotherapy FND plus rituximab is effective to induce a high clinical and molecular response in elderly patients with advanced stage follicular lymphoma (FL) at diagnosis. 2003 Vitolo, U; Boccomini, C; Ladetto, M; Pogliani, E; Scalabrini, Dr; Tarella, C; Castellino, C; Aglietta, M; Astolfi, M; Botto, B.; Carpaneto, A; Corradini, P; Darbesio, A; De Crescenzo, A; Levis, A; Liberati, Anna Marina
A case of acute myeloid leukemia with deletion of chromosome 7 following PBSC transplantation. 2000 Liberati, Anna Marina; Palumbo, Isabella; S., Scali; M., Trottini; M., Gambacorta; Donti, Emilio
A case of nodular sclerosis Hodgkin’s lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman’s disease: successful response to rituximab and radiotherapy. 2007 L., Falchi; D., Capello; Palumbo, Barbara; A., Rauco; R., Emili; M., Cianciulli; R., Pace; V., Capparella; F., Liberati; Liberati, Anna Marina
A continous recurrent course in a case of nodular-sclerosis (NS) classical Hodgkin's lymphoma (cHL) associated with Castleman's disease (CD) 2005 Rauco, A.; Liberati, F.; Capozzi, R.; Morandi, M.; Liberati, Anna Marina; Et, A.
A continous recurrent course in a case of nodular-sclerosis (NS) classical Hodgkin's lymphoma (cHL) associated with Castleman's disease (CD) 2005 Rauco, A; Liberati, F; Capozzi, R; Morandi, Mg; Pace, R; Capparella, V; Cianciulli, M; Liberati, Anna Marina
A Multicenter, Open Label Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma (MM) Patients 2016 Bringhen, S; Magarotto, V; Liberati, Anna Marina; Belotti, A; Larocca, A; Gilestro, M; Bonello, F; Gaidano, G; Bertazzoni, P; Stocchi, R; Ribolla, R; Di Sano, C; Patriarca, F; Passera, R; De Paoli, L; Oliva, S; Cafro, Am; Sonneveld, P; Palumbo, A; Boccadoro, M.
A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myeloma. 2016 Larocca, A; Bringhen, S; Petrucci, Mt; Oliva, S; Falcone, Ap; Caravita, T; Villani, O; Benevolo, G; Liberati, Anna Marina; Morabito, F; Montefusco, V; Passera, R; De Rosa, L; Omedé, P; Vincelli, Id; Spada, S; Carella, Am; Ponticelli, E; Derudas, D; Genuardi, M; Guglielmelli, T; Nozzoli, C; Aghemo, E; De Paoli, L; Conticello, C; Musolino, C; Offidani, M; Boccadoro, M; Sonneveld, P; Palumbo, A.
A phase I study of human natural interferon-beta in cancer patients. 1989 Liberati, Anna Marina; Biscottini, B; Fizzotti, M; Schippa, M; De Angelis, V; Senatore, M; Vittori, O; Teggia, L; Natali, R; Palmisano, L.
A phase II study of alpha interferon and oral arabinosyl cytosine (YNK01) in chronic myeloid leukemia. 2003 Rosti, G.; Bonifazi, F.; Trabacchi, ; De Vivo, A.; Bassi, S.; Martinelli, G.; Testoni, N.; Russo, D.; Baccarani M., for the Italian Cooperative Study Group on Chronic Myeloid Leucemia; Liberati, Anna Marina
A phase II study of alpha-interferon and oral arabinosyl cytosine (YNK01) in chronic myeloid leukemia. 2003 Active members of this study were A., Peta; F. Iuliano, Catanzaro; B., Rotoli; L. Luciano, Napoli; R., Fanin; M. Tiribelli, Udine; M., Boccadoro; D. Ferrero, Torino; G., Fioritoni; R. Di Lorenzo, Pescara; E., Volpe; F. Palmieri, Avellino; F. Frigeri, Napoli; F., Lauria; M. Bocchia, Siena; F., Grignani; Liberati, Anna Marina; Perugia, ; Am, Carella; CA Bodenizza, San Giovanni Rotondo; F., Mandelli; E. Montefusco, Roma; P., Leoni; S. Rupoli, Ancona; E., Gallo; M. Bertini, Torino; T., Chisesi; A. Polacco, Venezia; V., Liso; G. Specchia, Bari; G., Leone; S. Sica, Roma; A., Blasio; F. Ciccone, Latina; G., Pizzolo; A. Ambrosetti, Verona; E., Pogliani; C. Miccolis, Monza; A., Gabbas; D. Noli, Nuoro; P., Mazza; M. Cervellera, Taranto; GL Gaidano, Novara; MA Pistone, Cuneo; EM Schiavone, Napoli; E. Zuffa, Ravenna; R. Battista, Chioggia; S. Pardini, Sassari; M. Candela, Ancona; L. Garetto, Torino; M. Michieli, Aviano; C. Bergonzi, C. r. e. m. o. n. a. G. Rosti1
A Phase Iii Study of Enoxaparin Versus Aspirin Versus Low-dose Warfarin As Thromboprophylaxis For Patients With Newly Diagnosed Multiple Myeloma Treated Up-front With Thalidomide Based-regimens 2009 A., Palumbo; M., Cavo; S., Bringhen; F., Patriarca; D., Rossi; M. T., Petrucci; N., Pescosta; L. D., Rosa; Liberati, Anna Marina; A., Ledda; M., Rizzo; A., Granata; N. D., Renzo; L., Podda; S., Storti; D., Derudas; D., Cangini; R., Rizzi; L., Pantani; A., Baraldi; S., Palmieri; F., Gay; M. C., Pallotti; F. D., Raimondo; M., Boccadoro
A Phase III Study of Enoxaparin vs Aspirin vs Low-Dose Warfarin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Thalidomide Based-Regimens. 2009 A., Palumbo; M., Cavo; S., Bringhen; M., Cavalli; F., Patriarca; D., Rossi; P., Tacchetti; N., Pescosta; C., Crippa; M., Galli; T., Spadano; A. M., Carella; T., Caravita; C., Cellini; A., Ledda; F., Pisani; J., Peccatori; F., Elice; A., Nozza; V. D., Stefano; L. D., Rosa; Liberati, Anna Marina; F., Ciambelli; G. D., Sabbata; L., Catalano; A., Larocca; F., Morabito; E., Zamagni; M., Offidani; P., Tosi; M., Boccadoro